{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:24:50Z","timestamp":1793330690961,"version":"4.5.0"},"reference-count":104,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: Apart from classical elements in primary hyperparathyroidism (PHPT), non-classical complications, including type 2 diabetes mellitus (T2DM), are reported in some patients, but currently, they do not represent a parathyroidectomy (PTx) indication. Objective: to explore the latest data regarding glucose profile, particularly, T2DM and metabolic syndrome (MetS) in PHPT, including post-PTx. Methods: PubMed-based review included English-published original studies between January 2020 and December 2024 (n = 20). Results: Studied population: 764,485 subjects (female-to-male ratio of 1.26:1; 23,931 were PHPT patients vs. 740,502 controls). T2DM prevalence (n = 13; N = 763,645 patients; 55.92% females): 4\u201360% (higher vs. controls); for the largest study (N = 699,157) of 31.3%. Age-based analysis: higher T2DM prevalence at &gt;50 vs. &lt;50 years (14.4% vs. 2.6%, p &lt; 0.001), but not all studies agreed. Concurrent vitamin D deficiency as a contributor to a higher risk had limited evidence. The association MetS-PHPT (n = 2) had no clear conclusion. Post-PTx showed the following: lower glycaemia, fasting insulin, insulin resistance (HOMA-IR) improvement, and reduced rate (but not all studies agreed). PHPT patients with prediabetes might represent the population sub-group with the highest post-PTx benefit. Conclusions: The panel of PHPT-T2DM interplay remains heterogeneous. Data regarding post-PTx improvement of glucose disorders are still conflicting, recent findings suggested that surgery has beneficial effects, especially in patients with confirmed pre-existing prediabetes. Patients with the normocalcemic variant seemed to be less affected by the glucose-related disturbances, but further studies are needed. A better understanding of the intricate relationship between PHPT and glucose metabolism anomalies will help in providing optimal management to reduce the overall disease burden.<\/jats:p>","DOI":"10.3390\/life15040677","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T20:42:00Z","timestamp":1745268120000},"page":"677","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Hyperparathyroidism: An Analysis Amid the Co-Occurrence of Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"15","author":[{"given":"Ana-Maria","family":"Gheorghe","sequence":"first","affiliation":[{"name":"PhD Doctoral School of \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Stanciu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550024 Sibiu, Romania"},{"name":"Department of Endocrinology, Clinical County Emergency Hospital, 550245 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-5666","authenticated-orcid":false,"given":"Claudiu","family":"Nistor","sequence":"additional","affiliation":[{"name":"Department 4-Cardio-Thoracic Pathology, Thoracic Surgery II Discipline, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Thoracic Surgery Department, \u201cDr. Carol Davila\u201d Central Military University Emergency Hospital, 010242 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3938-705X","authenticated-orcid":false,"given":"Ioana Codruta","family":"Lebada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, \u201cLucian Blaga\u201d University of Sibiu, 550024 Sibiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-3835","authenticated-orcid":false,"given":"Mara","family":"Carsote","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Department of Clinical Endocrinology V, \u201cC.I. Parhon\u201d National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101247","DOI":"10.1016\/j.beem.2018.09.013","article-title":"Primary hyperparathyroidism","volume":"38","author":"Silva","year":"2024","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.suc.2024.02.008","article-title":"Primary Hyperparathyroidism: Part One: Evaluation","volume":"104","author":"Kurtom","year":"2024","journal-title":"Surg. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjsurg.2023.04.004","article-title":"Normohormonal primary hyperparathyroidism: A systematic review and meta-analysis","volume":"226","author":"Nabata","year":"2023","journal-title":"Am. J. Surg."},{"key":"ref_4","first-page":"2330","article-title":"Classical and Nonclassical Manifestations of Primary Hyperparathyroidism","volume":"37","author":"Chakhtoura","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Iwanowska, M., Kochman, M., Szatko, A., Zgliczy\u0144ski, W., and Glinicki, P. (2024). Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111639"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/reum\/170705","article-title":"Primary hyperparathyroidism: Clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines","volume":"61","author":"Kochman","year":"2023","journal-title":"Reumatologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus-Progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: Epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_11","first-page":"e40743","article-title":"Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings from a Scoping Review","volume":"15","author":"Barnett","year":"2023","journal-title":"Cureus"},{"key":"ref_12","first-page":"348","article-title":"Parathyroidectomy: Is vitamin D a player for a good outcome?","volume":"4","author":"Carsote","year":"2016","journal-title":"J. Med. Life"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4137\/CMED.S31292","article-title":"Parathyroidectomy Ameliorates Glucose and Blood Pressure Control in a Patient with Primary Hyperparathyroidism, Type 2 Diabetes, and Hypertension","volume":"8","author":"Kumar","year":"2015","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jss.2024.01.013","article-title":"Modern Trends for Primary Hyperparathyroidism: Intervening on Less Biochemically Severe Disease","volume":"296","author":"Krumeich","year":"2024","journal-title":"J. Surg. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.suc.2024.02.009","article-title":"Primary Hyperparathyroidism: Part Two: Surgical Management","volume":"104","author":"Kurtom","year":"2024","journal-title":"Surg. Clin. N. Am."},{"key":"ref_16","first-page":"47","article-title":"The Link Between Bone Osteocalcin and Energy Metabolism in a Group of Postmenopausal Women","volume":"45","author":"Dumitru","year":"2019","journal-title":"Curr. Health Sci. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"ref_18","first-page":"67","article-title":"Case Management of Delirium in Patients with Major Neurocognitive Disorders","volume":"CXXVIII","author":"Vasiliu","year":"2025","journal-title":"Rom. J. Mil. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg."},{"key":"ref_20","first-page":"204","article-title":"Spontaneous pneumothorax in a case of pulmonary langerhans cell histiocytosis","volume":"6","author":"Ciuche","year":"2011","journal-title":"Maedica"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-020-02519-7","article-title":"The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: A systematic review and meta-analysis","volume":"72","author":"Yavari","year":"2021","journal-title":"Endocrine"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Beysel, S., Caliskan, M., Kizilgul, M., Apaydin, M., Kan, S., Ozbek, M., and Cakal, E. (2019). Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc. Disord., 19.","DOI":"10.1186\/s12872-019-1093-4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1530\/EC-18-0259","article-title":"The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism","volume":"7","author":"Godang","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115812","DOI":"10.1016\/j.amjsurg.2024.115812","article-title":"Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management","volume":"235","author":"Wu","year":"2024","journal-title":"Am. J. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12020-024-04063-0","article-title":"Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations","volume":"86","author":"Barale","year":"2024","journal-title":"Endocrine"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Govind, K., Paruk, I.M., and Motala, A.A. (2024). Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: A single centre report from South Africa. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01583-8"},{"key":"ref_27","first-page":"e60965","article-title":"Clinical, Biochemical and Surgical Outcomes of Primary Hyperparathyroidism in the Present Era: A Prospective Study From a Tertiary Care Hospital","volume":"16","author":"Misgar","year":"2024","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.surg.2023.04.072","article-title":"Patients with prediabetes improve insulin resistance after surgery for primary hyperparathyroidism","volume":"175","author":"Bihain","year":"2024","journal-title":"Surgery"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/cen.15118","article-title":"Higher risk of incident diabetes among patients with primary hyperparathyroidism","volume":"101","author":"Zhang","year":"2024","journal-title":"Clin. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bibik, E.E., Dobreva, E.A., Elfimova, A.R., Miliutina, A.P., Eremkina, A.K., Gorbacheva, A.M., Krupinova, J.A., Koksharova, E.O., Sklyanik, I.A., and Mayorov, A.Y. (2023). Primary hyperparathyroidism in young patients is associated with metabolic disorders: A prospective comparative study. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-023-01302-9"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dobreva, E.A., Gorbacheva, A.M., Bibik, E.E., Eremkina, A.K., Elfimova, A.R., Salimkhanov, R.K., Kovaleva, E.V., Maganeva, I.S., and Mokrysheva, N.G. (2023). Cardiovascular and metabolic status in patients with primary hyperparathyroidism: A single-center experience. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1266728"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Iglesias, P., Arias, J., L\u00f3pez, G., Romero, I., and D\u00edez, J.J. (2023). Primary Hyperparathyroidism and Cardiovascular Disease: An Association Study Using Clinical Natural Language Processing Systems and Big Data Analytics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216718"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/jmh.jmh_142_22","article-title":"Differences in the Presentation and Outcome between Premenopausal and Postmenopausal Primary Hyperparathyroidism Indian Women: A Single-Center Experience","volume":"14","author":"Maldar","year":"2023","journal-title":"J. Mid-Life Health"},{"key":"ref_34","first-page":"56","article-title":"The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism","volume":"70","author":"Emral","year":"2023","journal-title":"Endocrinol. Diabetes Nutr. (Engl. Ed.)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.1210\/clinem\/dgad103","article-title":"Morbidity Associated with Primary Hyperparathyroidism-A Population-based Study with a Subanalysis on Vitamin D","volume":"108","author":"Lin","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.surg.2022.02.012","article-title":"Insulin resistance is more severe in patients with primary hyperparathyroidism","volume":"172","author":"Bihain","year":"2022","journal-title":"Surgery"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Al-Saleh, Y., AlSohaim, A., AlAmoudi, R., AlQarni, A., Alenezi, R., Mahdi, L., Alzanbaqi, H., Nawar, S.M., AlHarbi, H., and ALMulla, A. (2022). Primary hyperparathyroidism in Saudi Arabia revisited: A multi-centre observational study. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-01059-7"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Frey, S., Bourgade, R., Le May, C., Croyal, M., Bigot-Corbel, E., Renaud-Moreau, N., Wargny, M., Caillard, C., Miralli\u00e9, E., and Cariou, B. (2022). Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051373"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eprac.2021.09.012","article-title":"Comparison of Profile of Primary Hyperparathyroidism With and Without Type 2 Diabetes Mellitus: Retrospective Analysis from the Indian Primary Hyperparathyroidism Registry","volume":"28","author":"Kumari","year":"2022","journal-title":"Endocr. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00294","DOI":"10.1002\/edm2.294","article-title":"Assessment of insulin resistance in patients with primary hyperparathyroidism before and after Parathyroidectomy","volume":"4","author":"Milani","year":"2021","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jss.2019.07.019","article-title":"Rising Glucagon-Like Peptide 1 Concentrations After Parathyroidectomy in Patients with Primary Hyperparathyroidism","volume":"245","author":"Antonopoulou","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/a-1148-2546","article-title":"Moderators of the Association Between Serum Parathyroid Hormone and Metabolic Syndrome in Participants with Elevated Parathyroid Hormone: NHANES 2003\u20132006","volume":"52","author":"Chen","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107985","DOI":"10.1016\/j.diabres.2019.107985","article-title":"Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: A pilot study","volume":"160","author":"Karras","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Karras, S., Annweiler, C., Kiortsis, D., Koutelidakis, I., and Kotsa, K. (2020). Improving Glucose Homeostasis after Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism with Co-Existing Prediabetes. Nutrients, 12.","DOI":"10.3390\/nu12113522"},{"key":"ref_45","unstructured":"(2014, November 11). World Health Organization & International Diabetes Federation. Available online: https:\/\/iris.who.int\/handle\/10665\/43588."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2020). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care, 43, S14\u2013S31.","DOI":"10.2337\/dc20-S002"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-004-1335-5","article-title":"The EGIR-RISC STUDY (The European group for the study of insulin resistance: Relationship between insulin sensitivity cardiovascular disease risk): I. Methodology and objectives","volume":"47","author":"Hills","year":"2004","journal-title":"Diabetologia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem.87.1.8292","article-title":"Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention","volume":"87","author":"Janout","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/DMSO.S101624","article-title":"Clinical utility of metabolic syndrome severity scores: Considerations for practitioners","volume":"10","author":"DeBoer","year":"2017","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_53","first-page":"S435","article-title":"Bone mineral density and vitamin D levels in patients with rheumatoid arthritis","volume":"28","author":"Anghel","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chen, T., Wang, Y., Hao, Z., Hu, Y., and Li, J. (2021). Parathyroid hormone and its related peptides in bone metabolism. Biochem. Pharmacol., 192.","DOI":"10.1016\/j.bcp.2021.114669"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ecl.2021.07.005","article-title":"Physiology of Calcium Homeostasis: An Overview","volume":"50","author":"Matikainen","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101480","DOI":"10.1016\/j.molmet.2022.101480","article-title":"Parathyroid hormone (PTH) regulation of metabolic homeostasis: An old dog teaches us new tricks","volume":"60","author":"Rosen","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cellsig.2015.12.012","article-title":"Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase","volume":"28","author":"Larsson","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.ijo.0803066","article-title":"Parathyroid hormone is associated with decreased fat mass in young healthy women","volume":"30","author":"Gunther","year":"2006","journal-title":"Int. J. Obes."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1210\/jc.2012-3883","article-title":"Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients","volume":"98","author":"Ishimura","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jbmr\/zjae056","article-title":"Interactions between PTH and adiposity: Appetizing possibilities","volume":"39","author":"Bilezikian","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41366-018-0266-z","article-title":"Parathyroid hormone induces a browning program in human white adipocytes","volume":"43","author":"Hedesan","year":"2019","journal-title":"Int. J. Obes."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1590\/2359-3997000000306","article-title":"Thyroid disorders in obese patients. Does insulin resistance make a difference?","volume":"61","author":"Leach","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101705","DOI":"10.1016\/j.bonr.2023.101705","article-title":"Effects of PTH on osteoblast bioenergetics in response to glucose","volume":"19","author":"DeMambro","year":"2023","journal-title":"Bone Rep."},{"key":"ref_65","first-page":"129","article-title":"Hashimoto\u2019s thyroiditis and breast cancer: Coincidence or correlation?","volume":"51","author":"Valea","year":"2016","journal-title":"Arch. Balk. Med. Union"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2009.03.024","article-title":"Parathyroid hormone suppresses insulin signaling in adipocytes","volume":"307","author":"Chang","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00298433","article-title":"Parathyroid hormone decreases in vivo insulin effect on glucose utilization","volume":"57","author":"Saxe","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8414689","DOI":"10.1155\/2024\/8414689","article-title":"Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients","volume":"2024","author":"He","year":"2024","journal-title":"Int. J. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e53999","DOI":"10.7554\/eLife.53999","article-title":"Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes","volume":"9","author":"Tammineni","year":"2020","journal-title":"eLife"},{"key":"ref_70","first-page":"64","article-title":"Chronic autoimmune thyroiditis and obesity","volume":"53","author":"Valea","year":"2018","journal-title":"Arch. Balk. Med. Union"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Weiser, A., Feige, J.N., and De Marchi, U. (2021). Mitochondrial Calcium Signaling in Pancreatic \u03b2-Cell. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052515"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmet.2011.03.015","article-title":"Mitochondrial matrix calcium is an activating signal for hormone secretion","volume":"13","author":"Wiederkehr","year":"2011","journal-title":"Cell Metab."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Tarasov, A.I., Semplici, F., Ravier, M.A., Bellomo, E.A., Pullen, T.J., Gilon, P., Sekler, I., Rizzuto, R., and Rutter, G.A. (2012). The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic \u03b2-cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039722"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40618-020-01233-5","article-title":"Primary hyperparathyroidism and pancreatitis","volume":"43","author":"Misgar","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.12998\/wjcc.v12.i29.6302","article-title":"Recurrent acute pancreatitis as an initial presentation of primary hyperparathyroidism: A case report","volume":"12","author":"Karim","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"ref_76","first-page":"476","article-title":"Metastases in daily endocrine practice","volume":"51","author":"Carsote","year":"2016","journal-title":"Arch. Balk. Med. Union"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cipriani, C., Colangelo, L., Santori, R., Renella, M., Mastrantonio, M., Minisola, S., and Pepe, J. (2020). The Interplay Between Bone and Glucose Metabolism. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00122"},{"key":"ref_78","first-page":"78","article-title":"Gender-Dependent Associations Between Digit Ratio and Genetic Polymorphisms, BMI, and Reproductive Factors","volume":"128","author":"Nica","year":"2025","journal-title":"Rom. J. Mil. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"bqaa149","DOI":"10.1210\/endocr\/bqaa149","article-title":"Bone Regulation of Insulin Secretion and Glucose Homeostasis","volume":"161","author":"Ducy","year":"2020","journal-title":"Endocrinology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"117048","DOI":"10.1016\/j.bone.2024.117048","article-title":"Osteocalcin improves glucose tolerance, insulin sensitivity and secretion in older male mice","volume":"182","author":"Paracha","year":"2024","journal-title":"Bone"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3803\/EnM.2023.1895","article-title":"Osteocalcin: Beyond Bones","volume":"39","author":"Nowicki","year":"2024","journal-title":"Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00592-018-1101-7","article-title":"Insulin resistance and bone: A biological partnership","volume":"55","author":"Conte","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1172\/JCI72323","article-title":"Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation","volume":"124","author":"Wei","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_85","first-page":"1663","article-title":"Osteoporosis and diabetes: The dual pandemics","volume":"72","author":"Kalra","year":"2022","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4093\/dmj.2023.0112","article-title":"Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies","volume":"47","author":"Mesinovic","year":"2023","journal-title":"Diabetes Metab. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"496","DOI":"10.12680\/balneo.2022.496","article-title":"Medical management and rehabilitation in posttraumatic common peroneal nerve palsy","volume":"13","author":"Popa","year":"2022","journal-title":"Balneo PRM Res. J."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Liu, X., Chen, F., Liu, L., and Zhang, Q. (2023). Prevalence of osteoporosis in patients with diabetes mellitus: A systematic review and meta-analysis of observational studies. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-022-01260-8"},{"key":"ref_89","first-page":"6969040","article-title":"Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes","volume":"2016","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Kupai, K., Kang, H.L., P\u00f3sa, A., Csonka, \u00c1., V\u00e1rkonyi, T., and Valkusz, Z. (2024). Bone Loss in Diabetes Mellitus: Diaporosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137269"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00125-024-06172-x","article-title":"Bone metabolism in diabetes: A clinician\u2019s guide to understanding the bone-glucose interplay","volume":"67","author":"Sheu","year":"2024","journal-title":"Diabetologia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11914-024-00867-1","article-title":"Diagnosing Osteoporosis in Diabetes-A Systematic Review on BMD and Fractures","volume":"22","author":"Brandt","year":"2024","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Chuang, T.L., Chuang, M.H., Wang, Y.F., and Koo, M. (2022). Comparison of Trabecular Bone Score-Adjusted Fracture Risk Assessment (TBS-FRAX) and FRAX Tools for Identification of High Fracture Risk among Taiwanese Adults Aged 50 to 90 Years with or without Prediabetes and Diabetes. Medicina, 58.","DOI":"10.3390\/medicina58121766"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11154-024-09899-5","article-title":"Primary hyperparathyroidism: From guidelines to outpatient clinic","volume":"25","author":"Palermo","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00423-021-02173-1","article-title":"Management of primary and renal hyperparathyroidism: Guidelines from the German Association of Endocrine Surgeons (CAEK)","volume":"406","author":"Weber","year":"2021","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1007\/s00268-020-05711-y","article-title":"Risk Factors for Prolonged Length of Stay and Readmission After Parathyroidectomy for Renal Secondary Hyperparathyroidism","volume":"44","author":"Stefanova","year":"2020","journal-title":"World J. Surg."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.2147\/IJGM.S366725","article-title":"The Relationships Between Glycated Hemoglobin and Bone Turnover Markers in Patients with Type 2 Diabetes but No Diabetic Nephropathy","volume":"15","author":"Zhao","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/0886022X.2020.1841655","article-title":"Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism","volume":"42","author":"Kritmetapak","year":"2020","journal-title":"Ren. Fail."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ho, L.Y., Wong, P.N., Sin, H.K., Wong, Y.Y., Lo, K.C., Chan, S.F., Lo, M.W., Lo, K.Y., Mak, S.K., and Wong, A.K. (2017). Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol., 18.","DOI":"10.1186\/s12882-016-0421-5"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: Still a challenge in the post-operative management of primary hyperparathyroidism: A systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach","volume":"36","author":"Zavatta","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cen.14315","article-title":"Normocalcaemic primary hyperparathyroidism: An update on diagnostic and management challenges","volume":"93","author":"Dawood","year":"2020","journal-title":"Clin. Endocrinol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/4\/677\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:18:48Z","timestamp":1760030328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/4\/677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":104,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["life15040677"],"URL":"https:\/\/doi.org\/10.3390\/life15040677","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}